Paper25547792
Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
Rondini S and 9 others. Infect Immun, 2015. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium. Papers, record 25547792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25547792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Glycoconjugates | Major topic |
| O Antigens | Major topic |
| Salmonella Infections, Animal | Major topic |
| Salmonella Vaccines | Major topic |
| Salmonella typhimurium | Major topic |
| Animals | |
| Bacterial Proteins | |
| Diphtheria Toxin | |
| Drug Design | |
| Female | |
| Glycosylation | |
| Humans | |
| Liver | |
| Mice | |
| Mice, Inbred C57BL | |
| Mutation | |
| Recombinant Proteins | |
| Spleen | |
| Structure-Activity Relationship | |
| Vaccination |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BB/I002189/1 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23803904 | Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States. | Clin Vaccine Immunol | 2013 | https://conductscience.org/library/papers/23803904 | PubMed |
| 2 | 19477560 | Quadrivalent meningococcal conjugate vaccines. | Vaccine | 2009 | https://conductscience.org/library/papers/19477560 | PubMed |
| 3 | 10678970 | Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam. | Infect Immun | 2000 | https://conductscience.org/library/papers/10678970 | PubMed |
| 4 | 23142430 | A scalable method for O-antigen purification applied to various Salmonella serovars. | Anal Biochem | 2013 | https://conductscience.org/library/papers/23142430 | PubMed |
| 5 | 18953717 | Lipopolysaccharide: a tool and target in enterobacterial vaccine development. | Biol Chem | 2008 | https://conductscience.org/library/papers/18953717 | PubMed |
| 6 | 21248155 | Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi. | Clin Vaccine Immunol | 2011 | https://conductscience.org/library/papers/21248155 | PubMed |
| 7 | 21677750 | A conditional knockout resource for the genome-wide study of mouse gene function. | Nature | 2011 | https://conductscience.org/library/papers/21677750 | PubMed |
| 8 | 387597 | Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. | Infect Immun | 1979 | https://conductscience.org/library/papers/387597 | PubMed |
| 9 | 8698499 | Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. | Infect Immun | 1996 | https://conductscience.org/library/papers/8698499 | PubMed |
| 10 | 7529745 | Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. | Infect Immun | 1995 | https://conductscience.org/library/papers/7529745 | PubMed |
| 11 | 11422320 | Lipopolysaccharide O-chain microheterogeneity of Salmonella serotypes Enteritidis and Typhimurium. | Environ Microbiol | 2001 | https://conductscience.org/library/papers/11422320 | PubMed |
| 12 | 18628492 | Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella. | J Med Microbiol | 2008 | https://conductscience.org/library/papers/18628492 | PubMed |
| 13 | 6203984 | Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. | J Immunol | 1984 | https://conductscience.org/library/papers/6203984 | PubMed |
| 14 | 20133627 | Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133627 | PubMed |
| 15 | 6166555 | Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. | Infect Immun | 1981 | https://conductscience.org/library/papers/6166555 | PubMed |
| 16 | 3546260 | Lysogenic conversion of Salmonella typhimurium bacteriophages A3 and A4 consists of O-acetylation of rhamnose of the repeating unit of the O-antigenic polysaccharide chain. | J Bacteriol | 1987 | https://conductscience.org/library/papers/3546260 | PubMed |
| 17 | 19346477 | Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19346477 | PubMed |
| 18 | 1639490 | Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. | Infect Immun | 1992 | https://conductscience.org/library/papers/1639490 | PubMed |
| 19 | 19797066 | Effect of the O-antigen length of lipopolysaccharide on the functions of Type III secretion systems in Salmonella enterica. | Infect Immun | 2009 | https://conductscience.org/library/papers/19797066 | PubMed |
| 20 | 10496944 | Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice. | Infect Immun | 1999 | https://conductscience.org/library/papers/10496944 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42750268 | Critical Roles of O-Acetylation Revealed by Synthetic Trisaccharide Antigens for a Broad-Spectrum Anti-Salmonella Vaccine. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42750268 | PubMed |
| 42095411 | Synthetic O-Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non-Typhoidal Salmonella Serovars. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42095411 | PubMed |
| 41493384 | Multivalent vaccines for invasive Salmonella disease: need, rationale, and immunological foundations. | Infect Immun | 2026 | https://conductscience.org/library/papers/41493384 | PubMed |
| 41471961 | Characterization of a Luminescence-Based Serum Bactericidal Activity Assay for Human Sera Against a Panel of Salmonella Strains. | Microorganisms | 2025 | https://conductscience.org/library/papers/41471961 | PubMed |
| 40684736 | Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations. | Vaccine | 2025 | https://conductscience.org/library/papers/40684736 | PubMed |
| 40006669 | The Salmonella Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40006669 | PubMed |
| 39591175 | Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39591175 | PubMed |
| 38264668 | A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars. | Front Immunol | 2023 | https://conductscience.org/library/papers/38264668 | PubMed |
| 38006003 | Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38006003 | PubMed |
| 36234967 | Impact and Control of Sugar Size in Glycoconjugate Vaccines. | Molecules | 2022 | https://conductscience.org/library/papers/36234967 | PubMed |
| 34893630 | Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/34893630 | PubMed |
| 34638530 | Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638530 | PubMed |
| 34065899 | Long-Term Anti-Bacterial Immunity against Systemic Infection by Salmonella enterica Serovar Typhimurium Elicited by a GMMA-Based Vaccine. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34065899 | PubMed |
| 33671372 | A GMMA-CPS-Based Vaccine for Non-Typhoidal Salmonella. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33671372 | PubMed |
| 33451348 | The identification of novel immunogenic antigens as potential Shigella vaccine components. | Genome Med | 2021 | https://conductscience.org/library/papers/33451348 | PubMed |
| 32692622 | Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development. | Hum Vaccin Immunother | 2020 | https://conductscience.org/library/papers/32692622 | PubMed |
| 32535667 | Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM197 as carrier protein. | Glycoconj J | 2020 | https://conductscience.org/library/papers/32535667 | PubMed |
| 30262653 | Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30262653 | PubMed |
| 30143807 | Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines. | Adv Biochem Eng Biotechnol | 2021 | https://conductscience.org/library/papers/30143807 | PubMed |
| 29628924 | Defective Phagocytic Properties of HIV-Infected Macrophages: How Might They Be Implicated in the Development of Invasive Salmonella Typhimurium? | Front Immunol | 2018 | https://conductscience.org/library/papers/29628924 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25547792
GET https://conductscience.org/api/papers/v1/25547792/references?page=2